Literature DB >> 22041717

Second-generation arthroscopic autologous chondrocyte implantation for the treatment of degenerative cartilage lesions.

Giuseppe Filardo1, Elizaveta Kon, Alessandro Di Martino, Silvio Patella, Giulio Altadonna, Federica Balboni, Laura Bragonzoni, Andrea Visani, Maurilio Marcacci.   

Abstract

PURPOSE: Degenerative cartilage lesions present a negative joint environment, which may have a negative effect on the process of cartilage regeneration. The aim of this study is to analyze the clinical outcome obtained with the treatment for isolated degenerative knee cartilage lesions by second-generation arthroscopic autologous chondrocyte implantation (ACI).
METHODS: Fifty-eight consecutive patients affected by focal degenerative chondral lesions of the femoral condyles and trochlea were treated by second-generation arthroscopic ACI. The mean age at surgery was 34.7 ± 9.1 years and the average defect size was 2.3 ± 0.9 cm(2). The patients were prospectively evaluated with IKDC, EQ-VAS, and Tegner scores preoperatively, at 2 and 6 years.
RESULTS: A statistically significant improvement was observed in all scores from the basal evaluation to the final follow-up. The IKDC subjective score improved from 39.3 ± 13.6 to 68.8 ± 22.7 and 68.5 ± 23.9 at the 2- and 6-year follow-ups, respectively, with a significant improvement (P < 0.0005) and stable results over time; the same trend was confirmed by the EQ-VAS and Tegner scores. The worst results were found in patients with a low physical activity level, women, and those having undergone previous surgery, whereas the symptom duration before surgery did not influence the final outcome. The failure rate was 18.5%.
CONCLUSIONS: Despite a significant improvement, the results were lower with respect to the outcome reported in different study populations, and the number of failures was markedly higher, too. Tissue-engineered cartilage implantation is a promising approach for the treatment of degenerative chondral lesions, but graft properties, besides mechanical and biochemical joint environment, have to be improved. LEVEL OF EVIDENCE: Case series, Level IV.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22041717     DOI: 10.1007/s00167-011-1732-5

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  47 in total

1.  Matrix-associated autologous chondrocyte transplantation/implantation (MACT/MACI)--5-year follow-up.

Authors:  Peter Behrens; Thomas Bitter; Bodo Kurz; Martin Russlies
Journal:  Knee       Date:  2006-04-24       Impact factor: 2.199

Review 2.  Second generation issues in cartilage repair.

Authors:  Elizaveta Kon; Marco Delcogliano; Giuseppe Filardo; Clara Montaperto; Maurilio Marcacci
Journal:  Sports Med Arthrosc Rev       Date:  2008-12       Impact factor: 1.985

3.  Autologous chondrocyte implantation in the knee joint: open compared with arthroscopic technique. Comparison at a minimum follow-up of five years.

Authors:  Alberto Ferruzzi; Roberto Buda; Cesare Faldini; Francesca Vannini; Francesco Di Caprio; Deianira Luciani; Sandro Giannini
Journal:  J Bone Joint Surg Am       Date:  2008-11       Impact factor: 5.284

4.  Functional outcome of knee articular cartilage repair in adolescent athletes.

Authors:  Kai Mithöfer; Tom Minas; Lars Peterson; Howard Yeon; Lyle J Micheli
Journal:  Am J Sports Med       Date:  2005-07-06       Impact factor: 6.202

5.  Rating systems in the evaluation of knee ligament injuries.

Authors:  Y Tegner; J Lysholm
Journal:  Clin Orthop Relat Res       Date:  1985-09       Impact factor: 4.176

6.  Mid-term results of Autologous Matrix-Induced Chondrogenesis for treatment of focal cartilage defects in the knee.

Authors:  J Gille; E Schuseil; J Wimmer; J Gellissen; A P Schulz; P Behrens
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-02-02       Impact factor: 4.342

Review 7.  Cell carriers as the next generation of cell therapy for cartilage repair: a review of the matrix-induced autologous chondrocyte implantation procedure.

Authors:  Mats Brittberg
Journal:  Am J Sports Med       Date:  2009-12-04       Impact factor: 6.202

8.  Patient satisfaction and outcome after microfracture of the degenerative knee.

Authors:  Bruce S Miller; J Richard Steadman; Karen K Briggs; Juan J Rodrigo; William G Rodkey
Journal:  J Knee Surg       Date:  2004-01       Impact factor: 2.757

9.  Autologous chondrocyte implantation for joint preservation in patients with early osteoarthritis.

Authors:  Tom Minas; Andreas H Gomoll; Shahram Solhpour; Ralf Rosenberger; Christian Probst; Tim Bryant
Journal:  Clin Orthop Relat Res       Date:  2009-08-04       Impact factor: 4.176

10.  The effects of focal articular defects on cartilage contact mechanics.

Authors:  Kenneth R Gratz; Benjamin L Wong; Won C Bae; Robert L Sah
Journal:  J Orthop Res       Date:  2009-05       Impact factor: 3.494

View more
  30 in total

Review 1.  Surgical treatment for early osteoarthritis. Part I: cartilage repair procedures.

Authors:  A H Gomoll; G Filardo; L de Girolamo; J Espregueira-Mendes; J Esprequeira-Mendes; M Marcacci; W G Rodkey; J R Steadman; R J Steadman; S Zaffagnini; E Kon
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-11-24       Impact factor: 4.342

2.  Arthroscopic autologous chondrocyte implantation in the ankle joint.

Authors:  Sandro Giannini; Roberto Buda; Alberto Ruffilli; Marco Cavallo; Gherardo Pagliazzi; Maria Chiara Bulzamini; Giovanna Desando; Deianira Luciani; Francesca Vannini
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-09-01       Impact factor: 4.342

Review 3.  The current state of scaffolds for musculoskeletal regenerative applications.

Authors:  Benjamin D Smith; Daniel A Grande
Journal:  Nat Rev Rheumatol       Date:  2015-03-17       Impact factor: 20.543

Review 4.  Sport and early osteoarthritis: the role of sport in aetiology, progression and treatment of knee osteoarthritis.

Authors:  F Vannini; T Spalding; L Andriolo; M Berruto; M Denti; J Espregueira-Mendes; J Menetrey; G M Peretti; R Seil; G Filardo
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-04-04       Impact factor: 4.342

5.  Is the clinical outcome after cartilage treatment affected by subchondral bone edema?

Authors:  Giuseppe Filardo; Elizaveta Kon; Alessandro Di Martino; Francesco Perdisa; Maurizio Busacca; Francesco Tentoni; Federica Balboni; Maurilio Marcacci
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-12-14       Impact factor: 4.342

6.  Early resumption of physical activities leads to inferior clinical outcomes after matrix-based autologous chondrocyte implantation in the knee.

Authors:  Thomas R Niethammer; Peter E Müller; Elem Safi; Andreas Ficklscherer; Björn P Roßbach; Volkmar Jansson; Matthias F Pietschmann
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-07-10       Impact factor: 4.342

7.  Ten-year clinical and radiographic outcomes after autologous chondrocyte implantation of femoral condyles.

Authors:  David Martinčič; Damjan Radosavljevič; Matej Drobnič
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-11-21       Impact factor: 4.342

8.  Alignment does not influence cartilage T2 in asymptomatic knee joints.

Authors:  M Sauerschnig; J S Bauer; L Kohn; S Hinterwimmer; S Landwehr; K Woertler; P M Jungmann; W Koestler; P Niemeyer; A B Imhoff; G M Salzmann
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-11-29       Impact factor: 4.342

9.  Matrix based autologous chondrocyte implantation in children and adolescents: a match paired analysis in a follow-up over three years post-operation.

Authors:  Thomas Richard Niethammer; Martin Holzgruber; Mehmet Fatih Gülecyüz; Patrick Weber; Matthias Frank Pietschmann; Peter Ernst Müller
Journal:  Int Orthop       Date:  2016-11-08       Impact factor: 3.075

10.  Unicompartmental osteoarthritis: an integrated biomechanical and biological approach as alternative to metal resurfacing.

Authors:  M Marcacci; S Zaffagnini; E Kon; G M Marcheggiani Muccioli; A Di Martino; B Di Matteo; T Bonanzinga; F Iacono; G Filardo
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-01-31       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.